GSK Asks Again For Dismissal Of Wellbutrin IP Claims

Law360, New York (April 15, 2010, 1:49 PM EDT) -- GlaxoSmithKline PLC has asked a judge to reconsider its request to dismiss direct purchaser claims in a class action over the drugmaker's alleged filing of baseless patent suits to delay generic competition with antidepressant Wellbutrin SR.

The court should reconsider its decision to deny GSK's summary judgment request for claims alleged by the direct purchaser plaintiffs and Medical Mutual of Ohio, the drugmaker said in a motion filed Wednesday in the U.S. District Court for the Eastern District of Pennsylvania. In the alternative, GSK asked the...
To view the full article, register now.